These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2564287

  • 1. The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia.
    To LB, Haylock DN, Thorp D, Dyson PG, Branford AL, Ho JQ, Dart GD, Roberts MM, Horvath N, Bardy P.
    Bone Marrow Transplant; 1989 Jan; 4(1):41-7. PubMed ID: 2564287
    [Abstract] [Full Text] [Related]

  • 2. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [Abstract] [Full Text] [Related]

  • 3. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukaemia.
    To LB, Dyson PG, Branford AL, Russell JA, Haylock DN, Ho JQ, Kimber RJ, Juttner CA.
    Bone Marrow Transplant; 1987 Jun; 2(1):103-8. PubMed ID: 2901874
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 11. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 12. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
    Herrmann RP, O'Reilly J, Meyer BF, Lazzaro G.
    Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
    [Abstract] [Full Text] [Related]

  • 13. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H, Mulder NH, Willemse PH, van der Graaf WT, Sleijfer DT, Zijlstra JG, Elias M, Sibinga CT, Vellenga E, de Vries EG.
    Anticancer Res; 1995 Sep; 15(6B):2851-6. PubMed ID: 8669878
    [Abstract] [Full Text] [Related]

  • 14. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
    Weaver CH, Schulman KA, Buckner CD.
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
    Lowenthal RM, Fabères C, Marit G, Boiron JM, Cony-Makhoul P, Pigneux A, Agape P, Vezon G, Bouzgarou R, Dazey B, Fizet D, Bernard P, Lacombe F, Reiffers J.
    Bone Marrow Transplant; 1998 Oct; 22(8):763-70. PubMed ID: 9827973
    [Abstract] [Full Text] [Related]

  • 16. Experience with peripheral blood stem cell collection for autografts in children with active cancer.
    Takaue Y, Watanabe T, Abe T, Okamoto Y, Saito S, Shimizu T, Sato J, Hirao A, Suzue T, Koyama T.
    Bone Marrow Transplant; 1992 Sep; 10(3):241-8. PubMed ID: 1358378
    [Abstract] [Full Text] [Related]

  • 17. [Autografts of blood cells at various stages].
    Castaigne S, Dal Cortivo L, Leverger G, Miclea JM, Lepage E, Benbunan M, Gerota J, Degos L, Boiron M.
    Nouv Rev Fr Hematol (1978); 1988 Sep; 30(1-2):69-73. PubMed ID: 2898752
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, Sempere A, Soler MA, Marty ML, Sanz MA.
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [Abstract] [Full Text] [Related]

  • 19. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 20. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
    Strodtbeck D, Bornhäuser M, Hänel M, Lerche L, Schaich M, Illmer T, Thiede C, Geissler G, Herbst R, Ehninger G, Platzbecker U.
    Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.